VRC01LS is a humanized monoclonal antibody inhibitor that targets the CD4 binding site of the HIV-1 envelope glycoprotein (Env). By blocking the interaction between HIV-1 and the host cells CD4 receptor, VRC01LS inhibits viral entry. It holds potential for research in HIV-1 infection.
Target:
HIV Protease|||Virus Protease
* VAT and and shipping costs not included. Errors and price changes excepted
